The importance of chlamydia screening: A key step in sexual health.

Routine testing prevents complications and reduces transmission

Chlamydia is one of the most common sexually transmitted infections (STIs), yet it often goes undiagnosed because many people show no symptoms. Routine chlamydia screening is essential to prevent complications, reduce transmission, and promote sexual health. Chlamydia screening is quick, non-invasive, and effective, usually done with a urine sample or swab. Treatment with antibiotics is simple and highly effective.

Why screening is critical

• Asymptomatic nature: Up to 70% of women and 50% of men with chlamydia show no symptoms, making routine screening crucial to identify and treat infections early.
• Prevent serious complications: Untreated chlamydia can lead to pelvic inflammatory disease (PID) in women, causing infertility and chronic pain, while men can experience epididymitis and urethritis. Early detection prevents these long-term health issues.
• Reduce transmission: Chlamydia is highly contagious. Screening helps identify infected individuals, allowing for prompt treatment and reducing the spread of the infection within communities.
• Impact on pregnancy: Pregnant individuals with untreated chlamydia are at risk for preterm labor, low birth weight, and neonatal complications like conjunctivitis. Screening during pregnancy helps prevent these risks.

Who should be screened?

• All sexually active women under 25 should be screened annually.
• Pregnant women should be screened during their first prenatal visit.
• Men who have sex with men (MSM) and individuals with new or multiple sexual partners should be screened annually.
• Individuals with symptoms or known exposure should be tested as soon as possible.